Industry: Chemical & Material
Published Date: 2026-01-04
Pages: 79 Pages
Report ld: 5563753
Request Sample
Customized Report
Deoxynucleotide Triphosphates (dNTPs) Market Size(US$)

CAGR 2026-2032
7.3%
Market Size,2032
USD 325
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Deoxynucleotide Triphosphates (dNTPs) market size was US$ 200 million in 2025 and is forecast to reach a readjusted size of US$ 325 million by 2032 with a CAGR of 7.3% during the forecast period 2026-2032.
Deoxynucleotide triphosphates (dNTPs) are the nucleoside triphosphates containing deoxyribose. They are the building blocks of DNA, and they lose two of the phosphate groups when incorporated into DNA during replication.
On the basis of product type, solid type represent the largest share of the worldwide Deoxynucleotide Triphosphates market, with 75% share. North America holds the major share in the market, with a share of 43%.
The global Deoxynucleotide Triphosphates (dNTPs) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Deoxynucleotide Triphosphates (dNTPs) sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Deoxynucleotide Triphosphates (dNTPs) manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Deoxynucleotide Triphosphates (dNTPs) product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Deoxynucleotide Triphosphates (dNTPs) value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Deoxynucleotide Triphosphates (dNTPs) Product Scope
1.2 Deoxynucleotide Triphosphates (dNTPs) by Type
1.2.1 Global Deoxynucleotide Triphosphates (dNTPs) Sales by Type (2021, 2025 & 2032)
1.2.2 Liquid dNTPs
1.2.3 Solid dNTPs
1.3 Deoxynucleotide Triphosphates (dNTPs) by Application
1.3.1 Global Deoxynucleotide Triphosphates (dNTPs) Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Pharmaceutical
1.3.3 Research Institutions
1.4 Global Deoxynucleotide Triphosphates (dNTPs) Market Estimates and Forecasts (2021-2032)
1.4.1 Global Deoxynucleotide Triphosphates (dNTPs) Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Deoxynucleotide Triphosphates (dNTPs) Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Deoxynucleotide Triphosphates (dNTPs) Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Deoxynucleotide Triphosphates (dNTPs) Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Deoxynucleotide Triphosphates (dNTPs) Historical Market Scenario by Region (2021-2026)
2.2.1 Global Deoxynucleotide Triphosphates (dNTPs) Sales Market Share by Region (2021-2026)
2.2.2 Global Deoxynucleotide Triphosphates (dNTPs) Revenue Market Share by Region (2021-2026)
2.3 Global Deoxynucleotide Triphosphates (dNTPs) Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Deoxynucleotide Triphosphates (dNTPs) Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Deoxynucleotide Triphosphates (dNTPs) Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Deoxynucleotide Triphosphates (dNTPs) Market Size and Prospects (2021-2032)
2.4.2 Europe Deoxynucleotide Triphosphates (dNTPs) Market Size and Prospects (2021-2032)
2.4.3 China Taiwan Deoxynucleotide Triphosphates (dNTPs) Market Size and Prospects (2021-2032)
2.4.4 Japan Deoxynucleotide Triphosphates (dNTPs) Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Deoxynucleotide Triphosphates (dNTPs) Historical Market Review by Type (2021-2026)
3.1.1 Global Deoxynucleotide Triphosphates (dNTPs) Sales by Type (2021-2026)
3.1.2 Global Deoxynucleotide Triphosphates (dNTPs) Revenue by Type (2021-2026)
3.1.3 Global Deoxynucleotide Triphosphates (dNTPs) Average Price by Type (2021-2026)
3.2 Global Deoxynucleotide Triphosphates (dNTPs) Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Deoxynucleotide Triphosphates (dNTPs) Sales Forecast by Type (2027-2032)
3.2.2 Global Deoxynucleotide Triphosphates (dNTPs) Revenue Forecast by Type (2027-2032)
3.2.3 Global Deoxynucleotide Triphosphates (dNTPs) Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Deoxynucleotide Triphosphates (dNTPs)
4 Global Market Size by Application
4.1 Global Deoxynucleotide Triphosphates (dNTPs) Historical Market Review by Application (2021-2026)
4.1.1 Global Deoxynucleotide Triphosphates (dNTPs) Sales by Application (2021-2026)
4.1.2 Global Deoxynucleotide Triphosphates (dNTPs) Revenue by Application (2021-2026)
4.1.3 Global Deoxynucleotide Triphosphates (dNTPs) Average Price by Application (2021-2026)
4.2 Global Deoxynucleotide Triphosphates (dNTPs) Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Deoxynucleotide Triphosphates (dNTPs) Sales Forecast by Application (2027-2032)
4.2.2 Global Deoxynucleotide Triphosphates (dNTPs) Revenue Forecast by Application (2027-2032)
4.2.3 Global Deoxynucleotide Triphosphates (dNTPs) Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Deoxynucleotide Triphosphates (dNTPs) Applications
5 Competition Landscape by Players
5.1 Global Deoxynucleotide Triphosphates (dNTPs) Sales by Player (2021-2026)
5.2 Global Top Deoxynucleotide Triphosphates (dNTPs) Players by Revenue (2021-2026)
5.3 Global Deoxynucleotide Triphosphates (dNTPs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Deoxynucleotide Triphosphates (dNTPs) revenue as of 2025
5.4 Global Deoxynucleotide Triphosphates (dNTPs) Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Deoxynucleotide Triphosphates (dNTPs), Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Deoxynucleotide Triphosphates (dNTPs), Product Type & Application
5.7 Global Key Manufacturers of Deoxynucleotide Triphosphates (dNTPs), Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Deoxynucleotide Triphosphates (dNTPs) Sales by Company
6.1.1.1 North America Deoxynucleotide Triphosphates (dNTPs) Sales by Company (2021-2026)
6.1.1.2 North America Deoxynucleotide Triphosphates (dNTPs) Revenue by Company (2021-2026)
6.1.2 North America Deoxynucleotide Triphosphates (dNTPs) Sales Breakdown by Type (2021-2026)
6.1.3 North America Deoxynucleotide Triphosphates (dNTPs) Sales Breakdown by Application (2021-2026)
6.1.4 North America Deoxynucleotide Triphosphates (dNTPs) Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Deoxynucleotide Triphosphates (dNTPs) Sales by Company
6.2.1.1 Europe Deoxynucleotide Triphosphates (dNTPs) Sales by Company (2021-2026)
6.2.1.2 Europe Deoxynucleotide Triphosphates (dNTPs) Revenue by Company (2021-2026)
6.2.2 Europe Deoxynucleotide Triphosphates (dNTPs) Sales Breakdown by Type (2021-2026)
6.2.3 Europe Deoxynucleotide Triphosphates (dNTPs) Sales Breakdown by Application (2021-2026)
6.2.4 Europe Deoxynucleotide Triphosphates (dNTPs) Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Taiwan Market: Players, Segments, Downstream and Major Customers
6.3.1 China Taiwan Deoxynucleotide Triphosphates (dNTPs) Sales by Company
6.3.1.1 China Taiwan Deoxynucleotide Triphosphates (dNTPs) Sales by Company (2021-2026)
6.3.1.2 China Taiwan Deoxynucleotide Triphosphates (dNTPs) Revenue by Company (2021-2026)
6.3.2 China Taiwan Deoxynucleotide Triphosphates (dNTPs) Sales Breakdown by Type (2021-2026)
6.3.3 China Taiwan Deoxynucleotide Triphosphates (dNTPs) Sales Breakdown by Application (2021-2026)
6.3.4 China Taiwan Deoxynucleotide Triphosphates (dNTPs) Major Customers
6.3.5 China Taiwan Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Deoxynucleotide Triphosphates (dNTPs) Sales by Company
6.4.1.1 Japan Deoxynucleotide Triphosphates (dNTPs) Sales by Company (2021-2026)
6.4.1.2 Japan Deoxynucleotide Triphosphates (dNTPs) Revenue by Company (2021-2026)
6.4.2 Japan Deoxynucleotide Triphosphates (dNTPs) Sales Breakdown by Type (2021-2026)
6.4.3 Japan Deoxynucleotide Triphosphates (dNTPs) Sales Breakdown by Application (2021-2026)
6.4.4 Japan Deoxynucleotide Triphosphates (dNTPs) Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Thermo Scientific
7.1.1 Thermo Scientific Company Information
7.1.2 Thermo Scientific Business Overview
7.1.3 Thermo Scientific Deoxynucleotide Triphosphates (dNTPs) Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Thermo Scientific Deoxynucleotide Triphosphates (dNTPs) Products Offered
7.1.5 Thermo Scientific Recent Development
7.2 Merck Millipore
7.2.1 Merck Millipore Company Information
7.2.2 Merck Millipore Business Overview
7.2.3 Merck Millipore Deoxynucleotide Triphosphates (dNTPs) Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Merck Millipore Deoxynucleotide Triphosphates (dNTPs) Products Offered
7.2.5 Merck Millipore Recent Development
7.3 Promega
7.3.1 Promega Company Information
7.3.2 Promega Business Overview
7.3.3 Promega Deoxynucleotide Triphosphates (dNTPs) Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Promega Deoxynucleotide Triphosphates (dNTPs) Products Offered
7.3.5 Promega Recent Development
7.4 Meridian Bioscience
7.4.1 Meridian Bioscience Company Information
7.4.2 Meridian Bioscience Business Overview
7.4.3 Meridian Bioscience Deoxynucleotide Triphosphates (dNTPs) Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Meridian Bioscience Deoxynucleotide Triphosphates (dNTPs) Products Offered
7.4.5 Meridian Bioscience Recent Development
7.5 Jena Bioscience
7.5.1 Jena Bioscience Company Information
7.5.2 Jena Bioscience Business Overview
7.5.3 Jena Bioscience Deoxynucleotide Triphosphates (dNTPs) Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Jena Bioscience Deoxynucleotide Triphosphates (dNTPs) Products Offered
7.5.5 Jena Bioscience Recent Development
7.6 Takara Bio
7.6.1 Takara Bio Company Information
7.6.2 Takara Bio Business Overview
7.6.3 Takara Bio Deoxynucleotide Triphosphates (dNTPs) Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Takara Bio Deoxynucleotide Triphosphates (dNTPs) Products Offered
7.6.5 Takara Bio Recent Development
7.7 NEB
7.7.1 NEB Company Information
7.7.2 NEB Business Overview
7.7.3 NEB Deoxynucleotide Triphosphates (dNTPs) Sales, Revenue and Gross Margin (2021-2026)
7.7.4 NEB Deoxynucleotide Triphosphates (dNTPs) Products Offered
7.7.5 NEB Recent Development
7.8 Geneaid
7.8.1 Geneaid Company Information
7.8.2 Geneaid Business Overview
7.8.3 Geneaid Deoxynucleotide Triphosphates (dNTPs) Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Geneaid Deoxynucleotide Triphosphates (dNTPs) Products Offered
7.8.5 Geneaid Recent Development
8 Deoxynucleotide Triphosphates (dNTPs) Manufacturing Cost Analysis
8.1 Deoxynucleotide Triphosphates (dNTPs) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Deoxynucleotide Triphosphates (dNTPs)
8.4 Deoxynucleotide Triphosphates (dNTPs) Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Deoxynucleotide Triphosphates (dNTPs) Distributors List
9.3 Deoxynucleotide Triphosphates (dNTPs) Customers
10 Deoxynucleotide Triphosphates (dNTPs) Market Dynamics
10.1 Deoxynucleotide Triphosphates (dNTPs) Industry Trends
10.2 Deoxynucleotide Triphosphates (dNTPs) Market Drivers
10.3 Deoxynucleotide Triphosphates (dNTPs) Market Challenges
10.4 Deoxynucleotide Triphosphates (dNTPs) Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Deoxynucleotide Triphosphates (dNTPs) market was valued at US$ 200 million in 2025 and is anticipated to reach US$ 325 million by 2032, at a CAGR of 7.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 129
USD 2900.00
(Single User License)
The global market for Deoxynucleotide Triphosphates (dNTPs) was estimated to be worth US$ 200 million in 2025 and is projected to reach US$ 325 million, growing at a CAGR of 7.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 107
USD 3950.00
(Single User License)
The global Deoxynucleotide Triphosphates (dNTPs) market size was US$ 187 million in 2024 and is forecast to a readjusted size of US$ 305 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 80
USD 4250.00
(Single User License)
The global Deoxynucleotide Triphosphates (dNTPs) market is projected to grow from US$ 187 million in 2024 to US$ 305 million by 2031, at a CAGR of 7.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-08
Pages: 131
USD 4900.00
(Single User License)
In 2024, the global market size of Deoxynucleotide Triphosphates (dNTPs) was estimated to be worth US$ 187 million and is forecast to reach approximately US$ 305 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 127
USD 5900.00
(Single User License)
The global market for Deoxynucleotide Triphosphates (dNTPs) was estimated to be worth US$ 187 million in 2024 and is forecast to a readjusted size of US$ 305 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 106
USD 3950.00
(Single User License)
The global market for Deoxynucleotide Triphosphates (dNTPs) was valued at US$ 187 million in the year 2024 and is projected to reach a revised size of US$ 305 million by 2031, growing at a CAGR of 7.3% during the forecast period.
Published Date: 2025-01-18
Pages: 92
USD 2900.00
(Single User License)
Deoxynucleotide triphosphates (dNTPs) are the nucleoside triphosphates containing deoxyribose. They are the building blocks of DNA, and they lose two of the phosphate groups when incorporated into DNA during replication.
Published Date: 2024-04-17
Pages: 151
USD 5600.00
(Single User License)
Deoxynucleotide triphosphates (dNTPs) are the nucleoside triphosphates containing deoxyribose. They are the building blocks of DNA, and they lose two of the phosphate groups when incorporated into DNA during replication.
Published Date: 2024-04-16
Pages: 133
USD 5900.00
(Single User License)
Deoxynucleotide triphosphates (dNTPs) are the nucleoside triphosphates containing deoxyribose. They are the building blocks of DNA, and they lose two of the phosphate groups when incorporated into DNA during replication.
Published Date: 2024-04-07
Pages: 92
USD 4900.00
(Single User License)
The global Deoxynucleotide Triphosphates (dNTPs) market was valued at US$ 200 million in 2025 and is anticipated to reach US$ 325 million by 2032, at a CAGR of 7.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 129
The global market for Deoxynucleotide Triphosphates (dNTPs) was estimated to be worth US$ 200 million in 2025 and is projected to reach US$ 325 million, growing at a CAGR of 7.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 107
The global Deoxynucleotide Triphosphates (dNTPs) market size was US$ 187 million in 2024 and is forecast to a readjusted size of US$ 305 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 80
The global Deoxynucleotide Triphosphates (dNTPs) market is projected to grow from US$ 187 million in 2024 to US$ 305 million by 2031, at a CAGR of 7.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-08
Pages: 131
In 2024, the global market size of Deoxynucleotide Triphosphates (dNTPs) was estimated to be worth US$ 187 million and is forecast to reach approximately US$ 305 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 127
The global market for Deoxynucleotide Triphosphates (dNTPs) was estimated to be worth US$ 187 million in 2024 and is forecast to a readjusted size of US$ 305 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 106
The global market for Deoxynucleotide Triphosphates (dNTPs) was valued at US$ 187 million in the year 2024 and is projected to reach a revised size of US$ 305 million by 2031, growing at a CAGR of 7.3% during the forecast period.
Published: 2025-01-18
Pages: 92
Deoxynucleotide triphosphates (dNTPs) are the nucleoside triphosphates containing deoxyribose. They are the building blocks of DNA, and they lose two of the phosphate groups when incorporated into DNA during replication.
Published: 2024-04-17
Pages: 151
Deoxynucleotide triphosphates (dNTPs) are the nucleoside triphosphates containing deoxyribose. They are the building blocks of DNA, and they lose two of the phosphate groups when incorporated into DNA during replication.
Published: 2024-04-16
Pages: 133
Deoxynucleotide triphosphates (dNTPs) are the nucleoside triphosphates containing deoxyribose. They are the building blocks of DNA, and they lose two of the phosphate groups when incorporated into DNA during replication.
Published: 2024-04-07
Pages: 92
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now